BioLattice Ophthalmics, Inc.
Tuesday, June 04, 2024
Start-Up Stadium Session
Ophthalmology
5B
Company Description: We are addressing the need for tissue repair solutions, beginning with cornea. One in 70 patients who need cornea tissue obtain it. Globally 2 million per year suffer from corneal blindness while only 200,000 per year receive vision restoration via cornea transplant. There is no standard of care alternative to donor cornea tissue for full thickness cornea transplant material. Our engineered cornea will be a true alternative to donor cornea.
Company Website:
https://biolatticetech.com/
Company HQ City
Philadelphia
Company HQ State
PA
Company HQ Country
United States
CEO/Top Company Official
Amelia Zellander
Primary Speaker